Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2003-08-19 - 2003-12-16
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2003
Report date:
2003

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Dept. of Health, UK
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium mercaptoacetate
EC Number:
206-696-4
EC Name:
Sodium mercaptoacetate
Cas Number:
367-51-1
Molecular formula:
C2H4O2S.Na
IUPAC Name:
sodium sulfanylacetate
Constituent 2
Reference substance name:
NaTG
IUPAC Name:
NaTG
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Batch No. 5183
- Purity: 99.6 %

In vivo test system

Test animals

Species:
mouse
Strain:
CBA
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
propylene glycol
Concentration:
2.5%, 5%, 10% and 30% w/v in propylene glycol
No. of animals per dose:
4
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)

Results and discussion

Positive control results:
Hexylcinnamaldehyde was shown to be a skin sensitiser, confirming the validity of the protocol used for the study.

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Value:
1.17
Test group / Remarks:
2.5%
Parameter:
SI
Value:
2.32
Test group / Remarks:
5%
Key result
Parameter:
SI
Value:
6.7
Test group / Remarks:
10%
Remarks on result:
other: Table of stimulation indices can be found in the executive summary below.
Key result
Parameter:
EC3
Value:
4.7

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
NaTG 98 %, pure is a skin sensitiser.
Executive summary:

A sample of NaTG 98% was assessed for its skin sensitisation potential using the mouse Local Lymph Node Assay. The assay determines the level of T lymphocyte proliferation in the lymph nodes draining the site of chemical application, by measuring the amount of radiolabelled thymidine incorporated into the dividing cells. The test substance was initially applied as 0.25%, 0.5% or 1% w/v preparations in propylene glycol. A further group was subsequently dosed with a 2.5%, 5% or 10% w/v preparations in propylene glycol.

 

Concentration of test substance (% w/v)

Number of lymph nodes assayed

Disintegrations per minute (dpm)

dpm per lymph node

Test control ratio

0 (vehicle only)

8

1910

2.39

N/A

0.25

8

2213

2.77

1.16

0.5

8

3909

4.89

2.05

1.0

8

1756

2.2

0.92

0 (vehicle only)

8

4262

5.45

N/A

2.5

8

5102

6.38

1.17

5

8

10102

12.63

2.32

10

8

29199

36.5

6.7

 

The test substance was shown to have the capacity to cause skin sensitisation when applied as a 10% w/v preparation in propylene glycol.

In conclusion, NaTG 98% is a skin sensitiser.